MAPT and Alzheimer disease: As shown in a study by Mezache et al., the reduction in miR-512 expression and the increase in the expression of 2 of its antiapoptosis-related targets, cFLIP and MCL1, are associated with tau hyperphosphorylation in AD brains (Mezache et al., 2015).